Cancer Prevalence across Vertebrates.


Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
24 Oct 2024
Historique:
received: 22 04 2024
revised: 17 07 2024
accepted: 24 09 2024
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 24 10 2024
Statut: aheadofprint

Résumé

Cancer is pervasive across multicellular species, but what explains the differences in cancer prevalence across species? Using 16,049 necropsy records for 292 species spanning three clades of tetrapods (amphibians, sauropsids, and mammals), we found that neoplasia and malignancy prevalence increases with adult mass (contrary to Peto's paradox) and somatic mutation rate but decreases with gestation time. The relationship between adult mass and malignancy prevalence was only apparent when we controlled for gestation time. Evolution of cancer susceptibility appears to have undergone sudden shifts followed by stabilizing selection. Outliers for neoplasia prevalence include the common porpoise (<1.3%), the Rodrigues fruit bat (<1.6%), the black-footed penguin (<0.4%), ferrets (63%), and opossums (35%). Discovering why some species have particularly high or low levels of cancer may lead to a better understanding of cancer syndromes and novel strategies for the management and prevention of cancer. Significance: Evolution has discovered mechanisms for suppressing cancer in a wide variety of species. By analyzing veterinary necropsy records, we can identify species with exceptionally high or low cancer prevalence. Discovering the mechanisms of cancer susceptibility and resistance may help improve cancer prevention and explain cancer syndromes.

Identifiants

pubmed: 39445720
pii: 749321
doi: 10.1158/2159-8290.CD-24-0573
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

OF1-OF18

Subventions

Organisme : NCI NIH HHS
ID : U54 CA217376
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA272303
Pays : United States
Organisme : Congressionally Directed Medical Research Programs (CDMRP)
ID : BC132057
Organisme : Arizona Biomedical Research Commission (ABRC)
ID : ADHS18-198847
Organisme : Hyundai Hope On Wheels (Hope On Wheels)
Organisme : Agence Nationale de la Recherche (ANR)
ID : COVER ANR-23-CE02-0019
Organisme : Agence Nationale de la Recherche (ANR)
ID : OTKA K143421

Informations de copyright

©2024 The Authors; Published by the American Association for Cancer Research.

Auteurs

Zachary T Compton (ZT)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.
University of Arizona Cancer Center, Tucson, Arizona.
University of Arizona College of Medicine, Tucson, Arizona.

Walker Mellon (W)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.

Valerie K Harris (VK)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.

Shawn Rupp (S)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.

Diego Mallo (D)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.

Stefania E Kapsetaki (SE)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.

Mallory Wilmot (M)

Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

Ryan Kennington (R)

Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

Kathleen Noble (K)

Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

Cristina Baciu (C)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.
Department of Psychology, Arizona State University, Tempe, Arizona.

Lucia N Ramirez (LN)

Genomic Sciences Graduate Program, North Carolina State University, Raleigh, North Carolina.

Ashley Peraza (A)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.

Brian Martins (B)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.

Sushil Sudhakar (S)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.

Selin Aksoy (S)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.

Gabriela Furukawa (G)

Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

Orsolya Vincze (O)

Institute of Aquatic Ecology, Centre for Ecological Research, Debrecen, Hungary.
Evolutionary Ecology Group, Hungarian Department of Biology and Ecology, Babeş-Bolyai University, Cluj-Napoca, Romania.

Mathieu Giraudeau (M)

LIENSs, UMR 7266 CNRS-La Rochelle Université, La Rochelle, France.

Elizabeth G Duke (EG)

North Carolina State College of Veterinary Medicine, Raleigh, North Carolina.
Exotic Species Cancer Research Alliance, North Carolina State College of Veterinary Medicine, Raleigh, North Carolina.

Simon Spiro (S)

Wildlife Health Services, Zoological Society of London, London, United Kingdom.

Edmund Flach (E)

Wildlife Health Services, Zoological Society of London, London, United Kingdom.

Hannah Davidson (H)

North Carolina State College of Veterinary Medicine, Raleigh, North Carolina.
Exotic Species Cancer Research Alliance, North Carolina State College of Veterinary Medicine, Raleigh, North Carolina.

Christopher I Li (CI)

Translational Research Program and Epidemiology Program, Fred Hutchinson Cancer Center, Seattle, Washington.
Department of Epidemiology, University of Washington, Seattle, Washington.

Ashley Zehnder (A)

Exotic Species Cancer Research Alliance, North Carolina State College of Veterinary Medicine, Raleigh, North Carolina.

Trevor A Graham (TA)

Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.

Brigid V Troan (BV)

North Carolina State College of Veterinary Medicine, Raleigh, North Carolina.
Exotic Species Cancer Research Alliance, North Carolina State College of Veterinary Medicine, Raleigh, North Carolina.
The North Carolina Zoo, Asheboro, North Carolina.

Tara M Harrison (TM)

North Carolina State College of Veterinary Medicine, Raleigh, North Carolina.
Exotic Species Cancer Research Alliance, North Carolina State College of Veterinary Medicine, Raleigh, North Carolina.

Marc Tollis (M)

School of Informatics, Computing and Cyber Systems, Northern Arizona University, Flagstaff, Arizona.

Joshua D Schiffman (JD)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.
Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Peel Therapeutics, Inc., Salt Lake City, Utah.

C Athena Aktipis (CA)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.
School of Life Sciences, Arizona State University, Tempe, Arizona.

Lisa M Abegglen (LM)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.
Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Peel Therapeutics, Inc., Salt Lake City, Utah.

Carlo C Maley (CC)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.
School of Life Sciences, Arizona State University, Tempe, Arizona.
Biodesign Center for Biocomputing, Security and Society, Arizona State University, Tempe, Arizona.

Amy M Boddy (AM)

Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, Arizona.
University of California Santa Barbara, Santa Barbara, California.

Classifications MeSH